Inovio Pharmaceuticals Hit with Securities Class Action Over False Claims of Developing COVID-19 Vaccine
March 17, 2020 A class action says Inovio Pharmaceuticals stockholders were injured when it was revealed that the company, despite its claims, had not developed a COVID-19 vaccine.